Drug Shortage Report for SANDOZ CANDESARTAN PLUS
Report ID | 73123 |
Drug Identification Number | 02327902 |
Brand name | SANDOZ CANDESARTAN PLUS |
Common or Proper name | CANDESARTAN PLUS |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL |
Strength(s) | 12.5MG 16MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-11-01 |
Estimated end date | 2020-08-07 |
Actual end date | 2020-08-03 |
Shortage status | Resolved |
Updated date | 2020-08-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v41 | 2020-08-24 | English | Compare |
v42 | 2020-08-24 | French | Compare |